CDK1 and colorectal carcinoma: The above results supported that miR-378a-5p inhibited proliferation but promoted the apoptosis of CRC cells, while CDK1 reversed these effects; overexpressing CDK1 reversed the inhibition of miR-378a-5p overexpression on CRC cell proliferation, demonstrating the targeting relationship between the two.